Abstract
Isoprinosine (NPT-10381) was given orally to a group of 22 volunteers at a daily dose of 6 g for 7 days; a control group of 23 volunteers received placebo. Volunteers were inoculated intranasally with both rhinovirus type 9 and rhinovirus type 31, and the clinical picture, extent of virus shedding, and serological responses were assessed. There was no evidence that the compound had useful antiviral activity under the conditions of this trial.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Muldoon R. L., Mezny L., Jackson G. G. Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrob Agents Chemother. 1972 Sep;2(3):224–228. doi: 10.1128/aac.2.3.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stott E. J., Tyrrell D. A. Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch. 1968;23(3):236–244. doi: 10.1007/BF01241896. [DOI] [PubMed] [Google Scholar]
- TYRRELL D. A. THE USE OF VOLUNTEERS. Am Rev Respir Dis. 1963 Sep;88:SUPPL–134. doi: 10.1164/arrd.1963.88.3P2.128. [DOI] [PubMed] [Google Scholar]